About Glycosan
Glycosan is a company based in Alameda (United States) founded in 2006 was acquired by Lineage Cell Therapeutics in February 2011.. Glycosan has raised $950 thousand across 5 funding rounds from investors including Lineage Cell Therapeutics and HHS. Glycosan operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Alameda, United States
-
Sectors
HealthcareChemicals & Materials
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$950 K (USD)
in 5 rounds
-
Latest Funding Round
$625 K (USD), Seed
May 13, 2010
-
Investors
Lineage Cell Therapeutics
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Lineage Cell Therapeutics
(Feb 14, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Glycosan
Glycosan has successfully raised a total of $950K across 5 strategic funding rounds. The most recent funding activity was a Seed round of $625 thousand completed in May 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Seed — $625,000
-
First Round
First Round
(30 Jul 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2010 | Amount | Seed - Glycosan | Valuation |
investors |
|
| Jan, 2010 | Amount | Grant - Glycosan | Valuation |
investors |
|
| Dec, 2009 | Amount | Grant - Glycosan | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Glycosan
Glycosan has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Lineage Cell Therapeutics and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Lineage Cell Therapeutics is focused on developing allogeneic cell therapies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Glycosan
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Glycosan
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Glycosan Comparisons
Competitors of Glycosan
Glycosan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Glycosan
Frequently Asked Questions about Glycosan
When was Glycosan founded?
Glycosan was founded in 2006 and raised its 1st funding round 3 years after it was founded.
Where is Glycosan located?
Glycosan is headquartered in Alameda, United States. It is registered at Alameda, California, United States.
Is Glycosan a funded company?
Glycosan is a funded company, having raised a total of $950K across 5 funding rounds to date. The company's 1st funding round was a Grant of $106.85K, raised on Jul 30, 2009.
What does Glycosan do?
Glycosan was founded in 2006 in Alameda, United States, focusing on biotechnology for regenerative medicine and tissue engineering. Biocompatible hydrogels, including the proprietary Extracel technology, are created to support stem cell growth and differentiation. These materials serve as implantable, resorbable matrices. The company was acquired by BioTime in February 2011, integrating its operations into broader stem cell research efforts.
Who are the top competitors of Glycosan?
Glycosan's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Who are Glycosan's investors?
Glycosan has 2 investors. Key investors include Lineage Cell Therapeutics, and HHS.